High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia
Abstract
In male patients with congenital adrenal hyperplasia, testicular tumors, or so-called adrenal rest tumors, have been described, but their presence in well controlled patients is thought to be rare. In this study, the prevalence of testicular tumors in 17 adolescent and adult male patients with congenital adrenal hyperplasia (age, 16-40 yr) was investigated. In 16 of 17 patients, one or more testicular tumors, ranging in maximal length from 0.2-4.0 cm, were found on ultrasonography. In 6 patients, the testicular tumors were palpable. Undertreatment, defined as the presence of a salivary androstenedione level (mean of 6 saliva samples collected over 24 h with intervals of 4 h) above the upper reference morning level, was found in 5 of 17 patients at the time of investigation. The other 12 patients were treated adequately or even over treated at the time of investigation. Nevertheless, 11 of these 12 patients showed testicular tumors on ultrasonography. Neither the presence of undertreatment at the time of investigation nor characteristics of the therapeutic regimen (daily dose of hydrocortisone equivalents per body surface, the use of glucocorticoid medication either two or three times a day, or the time of taking the highest glucocorticoid dose either in the morning or the evening) could predict tumor size (maximal diameter of largest tumor). In patients who were heterozygous or homozygous for the deletion or conversion of the CYP21 gene, tumor size was significantly larger than in patients who did not have this genotype. Impairment of Leydig cell function as manifested by decreased plasma levels of T was found in 6 of 17 patients. Semen analysis in 11 patients revealed azoospermia in 3 patients and poor semen quality in 4 patients. We conclude that, when carefully sought for, testicular adrenal rest tumors are frequently present in adolescent and adult males with congenital adrenal hyperplasia and are often accompanied by impaired spermatogenesis and Leydig cell failure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the virilizing forms of CAH, excess adrenal sex steroids can lead to hypogonadotropic hypogonadism and increased progesterone can interfere with endometrial implantation.
“In the virilizing forms of CAH, excess adrenal sex steroids can lead to hypogonadotropic hypogonadism 106,107 and increased progesterone can interfere with endometrial implantation.108,109”
From Congenital adrenal hyperplasia (2017) · cites this paper as [107]
The prevalence of TART is between 44-94% of men with classic 21OH.
“The prevalence of TART is between 44-94% of men 98,107,114,115”
From Congenital adrenal hyperplasia (2017) · cites this paper as [107]
Fertility in males with CAH is often impaired.
“Fertility in males with CAH is often impaired (226, 237, 248-250).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [250]
The citation lists haven’t been fetched yet
References 35 · Cited by 305
- Authors
- Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M.
- Affiliations
- Radboud University Nijmegen (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-12
- Volume
- 86
- Issue
- 12
- Pages
- 5721-5728
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2131957162
- Cited by
- 305
- References
- 35
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 8 · 2023: 13 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 17 · 2018: 11 · 2017: 19 · 2016: 12 · 2015: 18 · 2014: 13 · 2013: 11 · 2012: 12
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Keywords
- testicular adrenal rest tumor, congenital adrenal hyperplasia, impaired spermatogenesis, undertreatment, azoospermia, semen quality, androgen deficiency, cancer prevalence
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenal Rest Tumor, Adult, Androstenedione, Follicle Stimulating Hormone, Humans, Leydig Cells, Luteinizing Hormone, Male, Oligospermia, Saliva, Semen, Spermatogenesis, Testicular Neoplasms, Testis, Testosterone, Ultrasonography, Prevalence, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review